Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study, and standardized the Intervention/Treatment heading. The previous revision note Revision: v3.5.5 was removed and replaced with Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T12:20:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects a newer version of the page release.
    Difference
    0.1%
    Check dated 2026-06-05T08:26:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated revision tag from v3.5.3 to v3.5.4, indicating a newer version of the page metadata.
    Difference
    0.1%
    Check dated 2026-05-15T04:13:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a small update to the page's revision history and release notes.
    Difference
    0.1%
    Check dated 2026-04-30T18:34:41.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:47:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Layout and formatting updates to the study record page were observed. Core study content like eligibility criteria, outcomes, and enrollment status remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-25T21:00:33.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.